Am J Transplant, Volume 21, Suppl 3 Archives - Page 44 of 139 - ATC Abstracts

2021 American Transplant Congress
A Case of Graft-versus-Host Disease Following Pancreas-Kidney Transplant
P. Shelat¹, C. Alquist²
¹Pathology, University of Cincinnati Medical Center, Cincinnati, OH, ²Transplantation Immunology Division, Hoxworth Blood Center, Cincinnati, OH
*Purpose: Graft-versus-host disease (GvHD) is an uncommon but often fatal complication following solid organ transplantation. It occurs when immunocompetent donor T cells are transferred to…
2021 American Transplant Congress
Non-Alcoholic Fatty Liver Disease in Non-Liver Transplant Patients
R. Claudio¹, C. Conceicao², K. Robichaux², A. Kumar¹, J. Buggs³, N. Kemmer⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: The global prevalence of non-alcoholic fatty liver disease (NAFLD) is rising at an alarming rate, driven in large part by an increased incidence of…
2021 American Transplant Congress
Dynamics of IgG Subclass as a Mechanism of Desensitization Using Rituximab for Presensitized Patients Undergoing Living Related Liver Transplantation
H. Egawa¹, K. Ide², T. Ishizuka³, H. Ohdan⁴, Y. Kotera¹, T. Kato¹, A. Ohmori¹, Y. Hirata¹, G. Shibuya¹, S. Yamashita¹, S. Ariizumi¹
¹Tokyo Women's Medical University, Tokyo, Japan, ²Surgery, Hiroshima University, Hiroshima, Japan, ³Clinical Laboratory, Tokyo Women's Medical University, Tokyo, Japan, ⁴Hiroshima University, Hiroshima, Japan
*Purpose: Although impact of preformed HLA-related donor specific antibody (DSA) and necessity of desensitization in liver transplantation (LT) has been recognized, mechanisms of desensitization in…
2021 American Transplant Congress
Pilot Evaluation of Prognosis After Liver Transplantation in Patients with a History of Hepatocellular Carcinoma and Pd-1 Inhibition
M. Chen¹, Z. Chen¹, X. Lin²
¹First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²the Eastern Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: The successful applications of programmed death protein-1 (PD-1) inhibitors in cancer therapy has led to an expanding use of immunotherapy in oncolog Liver transplantation…
2021 American Transplant Congress
Update on Domino Liver Transplants – A Registry Report
R. Gruessner, J. Renz, A. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: The ongoing shortage of livers in the setting of a growing waiting list remains a challenge in transplantation. First introduced in 1996, domino liver…
2021 American Transplant Congress
Time-averaged Oxygen Saturation During Donor Agonal Phase is Associated with Post-transplant Hepatic Graft Survival
K. C. Eddinger¹, E. M. Sonnenberg¹, A. Kayastha², N. Mahmud³, D. E. Schaubel², P. L. Abt¹
¹Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ³Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Livers harvested from donors after cardiac death (DCD) are subjected to a period of relative warm ischemia during the agonal phase. There have been…
2021 American Transplant Congress
Impact of Liver Acuity Circles on Timing of Donor Procurements
R. Radhakrishnan, D. Goldberg
University of Miami, Miami, FL
*Purpose: The Acuity Circles (AC) policy in liver transplantation led to broader organ sharing, whereby many organ procurement organization (OPOs) had to coordinate organ offers…
2021 American Transplant Congress
Peripheral Lymphocyte Profiling and Increased Risk of EBV Infection in Pediatric Liver Transplant Recipients
V. M. Novara Gennuso¹, T. Miloh²
¹Pediatrics, Miller School of Medicine- University of Miami, Miami, FL, ²Pediatrics, Miami Transplant Institute, Miami, FL
*Purpose: Epstein-Barr virus “EBV” infection and post-transplant lymphoproliferative disorders “PTLD” are significant comorbidities in the post-transplant “PT” setting, especially in pediatrics. The synergy among T…
2021 American Transplant Congress
A Case-Match Cohort Comparison of the Safety and Efficacy of Basiliximab for Immunosuppression Holiday in Lung Transplant Patients
M. M. Eiting¹, J. E. Clark¹, T. L. Astor², J. Palafox², C. Rogers Marks¹, G. Waldman¹
¹Pharmacy, Massachusetts General Hospital, Boston, MA, ²Massachusetts General Hospital, Boston, MA
*Purpose: Post-transplant complications related to calcineurin inhibitors (CNI) maintenance immunosuppression (MI) may require interim alternative therapies. The goal of this study is to evaluate the…
2021 American Transplant Congress
Bilateral Lung Transplantation for Destroyed Lungs with Asymmetric Thorax
B. Yue, J. Chen
Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, China
*Purpose: Destroyed lungs can cause mediastinal displacement, asymmetric chest deformity, and high risk and difficulty of surgery. Until now, there are few reports about bilateral…